MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Companies: Acquired_(M&A)
SmartCells
Parents
*Architects: Diabetes, Metabolic Disease, Dialysis, Renal & Kidney Companies (Pharmaceuticals, Biotechnology, Biosimilars)
Companies: Acquired_(M&A)
Children
2010: Merck to Acquire SmartCells, Inc. for $500m (2010)
August 1, 2009 – SmartCells, Inc. Receives Additional Phase II SBIR Funds from NIH/NIDDK
Beverly, Massachusetts
Biotech has some intriguing insulin technology that originated at MIT, SmartCells
Developing a glucose responsive insulin formulation for the treatment of diabetes mellitus
June 17, 2010 - SmartCells Completes Series D Preferred Stock Financing
September 25, 2009 – SmartCells, Inc. Awarded Phase II SBIR by NIH/NIDDK
With an eye on remaining one of the leaders in the diabetes field, Merck (NYSE:MRK) has agreed to pay more than $500 million to acquire SmartCells